{"id":"https://openalex.org/W4386550249","doi":"https://doi.org/10.1056/nejmp2306872","title":"The Accelerated Approval Program for Cancer Drugs \u2014 Finding the Right Balance","display_name":"The Accelerated Approval Program for Cancer Drugs \u2014 Finding the Right Balance","publication_year":2023,"publication_date":"2023-09-08","ids":{"openalex":"https://openalex.org/W4386550249","doi":"https://doi.org/10.1056/nejmp2306872","pmid":"https://pubmed.ncbi.nlm.nih.gov/37694884"},"language":"en","primary_location":{"id":"doi:10.1056/nejmp2306872","doi":"https://doi.org/10.1056/nejmp2306872","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejmp2306872","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033279700","display_name":"Bishal Gyawali","orcid":"https://orcid.org/0000-0001-7444-8594","observed_orcids":["https://orcid.org/0000-0001-7444-8594"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I204722609","display_name":"Queen's University","ror":"https://ror.org/02y72wh86","country_code":"CA","type":"education","lineage":["https://openalex.org/I204722609"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Bishal Gyawali","raw_affiliation_strings":["From the Division of Cancer Care and Epidemiology, Department of Oncology and Department of Public Health Sciences, Queen\u2019s University, Kingston, ON, Canada (B.G.); the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston (B.G., A.S.K.); and the Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, and the Department of Health Policy and Management, Yale School of Public Health \u2014 both in New Haven, CT (J.S.R.)","Division of Cancer Care and Epidemiology, Department of Oncology and Department of Public Health Sciences, Queen's University, Kingston, ON, Canada, and the Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine","Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, and the Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine"],"raw_orcid":"https://orcid.org/0000-0001-7444-8594","affiliations":[{"raw_affiliation_string":"From the Division of Cancer Care and Epidemiology, Department of Oncology and Department of Public Health Sciences, Queen\u2019s University, Kingston, ON, Canada (B.G.); the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston (B.G., A.S.K.); and the Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, and the Department of Health Policy and Management, Yale School of Public Health \u2014 both in New Haven, CT (J.S.R.)","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I204722609"]},{"raw_affiliation_string":"Division of Cancer Care and Epidemiology, Department of Oncology and Department of Public Health Sciences, Queen's University, Kingston, ON, Canada, and the Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine","institution_ids":["https://openalex.org/I204722609"]},{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, and the Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074257304","display_name":"Aaron Seth Kesselheim","orcid":"https://orcid.org/0000-0002-8867-2666","observed_orcids":["https://orcid.org/0000-0002-8867-2666"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I204722609","display_name":"Queen's University","ror":"https://ror.org/02y72wh86","country_code":"CA","type":"education","lineage":["https://openalex.org/I204722609"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Aaron S. Kesselheim","raw_affiliation_strings":["From the Division of Cancer Care and Epidemiology, Department of Oncology and Department of Public Health Sciences, Queen\u2019s University, Kingston, ON, Canada (B.G.); the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston (B.G., A.S.K.); and the Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, and the Department of Health Policy and Management, Yale School of Public Health \u2014 both in New Haven, CT (J.S.R.)","Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, and the Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Cancer Care and Epidemiology, Department of Oncology and Department of Public Health Sciences, Queen\u2019s University, Kingston, ON, Canada (B.G.); the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston (B.G., A.S.K.); and the Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, and the Department of Health Policy and Management, Yale School of Public Health \u2014 both in New Haven, CT (J.S.R.)","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I204722609"]},{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, and the Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031832642","display_name":"Joseph S. Ross","orcid":"https://orcid.org/0000-0002-9218-3320","observed_orcids":["https://orcid.org/0000-0002-9218-3320"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I204722609","display_name":"Queen's University","ror":"https://ror.org/02y72wh86","country_code":"CA","type":"education","lineage":["https://openalex.org/I204722609"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Joseph S. Ross","raw_affiliation_strings":["From the Division of Cancer Care and Epidemiology, Department of Oncology and Department of Public Health Sciences, Queen\u2019s University, Kingston, ON, Canada (B.G.); the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston (B.G., A.S.K.); and the Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, and the Department of Health Policy and Management, Yale School of Public Health \u2014 both in New Haven, CT (J.S.R.)","Department of Health Policy and Management, Yale School of Public Health \u2014 both in New Haven, CT"],"raw_orcid":"https://orcid.org/0000-0002-9218-3320","affiliations":[{"raw_affiliation_string":"From the Division of Cancer Care and Epidemiology, Department of Oncology and Department of Public Health Sciences, Queen\u2019s University, Kingston, ON, Canada (B.G.); the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston (B.G., A.S.K.); and the Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, and the Department of Health Policy and Management, Yale School of Public Health \u2014 both in New Haven, CT (J.S.R.)","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I204722609"]},{"raw_affiliation_string":"Department of Health Policy and Management, Yale School of Public Health \u2014 both in New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.1284,"has_fulltext":false,"cited_by_count":46,"citation_normalized_percentile":{"value":0.97597538,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"389","issue":"11","first_page":"968","last_page":"971"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8036999702453613,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8036999702453613,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.08950000256299973,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.026399999856948853,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/accelerated-approval","display_name":"accelerated approval","score":0.8330000042915344},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.8830000162124634},{"id":"https://openalex.org/keywords/fda-guidance","display_name":"FDA guidance","score":0.8299999833106995},{"id":"https://openalex.org/keywords/regulatory-policy","display_name":"regulatory policy","score":0.6990000009536743},{"id":"https://openalex.org/keywords/drug-approval-pathways","display_name":"drug approval pathways","score":0.6600000262260437},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.36399999260902405}],"concepts":[{"id":"https://openalex.org/C3020340455","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Cancer drugs","level":3,"score":0.71348637342453},{"id":"https://openalex.org/C168031717","wikidata":"https://www.wikidata.org/wiki/Q1530280","display_name":"Balance (ability)","level":2,"score":0.5402601957321167},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.5393566489219666},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3864861726760864},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37345534563064575},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.185220867395401},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.18445497751235962},{"id":"https://openalex.org/C99508421","wikidata":"https://www.wikidata.org/wiki/Q2678675","display_name":"Physical medicine and rehabilitation","level":1,"score":0.08441853523254395},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.06482872366905212}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000458","qualifier_name":"organization & administration","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1056/nejmp2306872","doi":"https://doi.org/10.1056/nejmp2306872","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejmp2306872","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:37694884","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37694884","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.7246000170707703,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W3177957358","https://openalex.org/W3197690460","https://openalex.org/W4214704026","https://openalex.org/W4366463854"],"related_works":["https://openalex.org/W4378838988","https://openalex.org/W4366438978","https://openalex.org/W4296698983","https://openalex.org/W4322422828","https://openalex.org/W4210883078","https://openalex.org/W3110832574","https://openalex.org/W4388672307","https://openalex.org/W168188393","https://openalex.org/W4210538987","https://openalex.org/W4413141010"],"abstract_inverted_index":{"Recently,":[0],"the":[1,8,16],"FDA":[2],"proposed":[3],"guidance":[4,17],"that":[5],"would":[6],"update":[7],"accelerated":[9],"approval":[10],"pathway":[11],"for":[12],"cancer":[13],"drugs.":[14],"Although":[15],"includes":[18],"important":[19],"provisions,":[20],"it":[21],"could":[22],"be":[23],"strengthened.":[24]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":22},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-09-09T00:00:00"}